I. Source of Curcumin

Curcumin is a characteristic active polyphenolic compound unique to plants of the genus Curcuma in the Zingiberaceae family, and it is also the core substance for these plants to exert physiological effects. Its main natural source is the dried rhizome of Curcuma longa L., and it is also distributed in small amounts in related plants of the Zingiberaceae family such as Curcuma aromatica Salisb., Curcuma zedoaria (Christm.) Rosc., and Zingiber officinale Rosc. Among them, the rhizome of Curcuma longa L. has the highest curcumin content, making it the main raw material source for industrial production and scientific research applications. The traditional method of obtaining curcumin is mainly plant extraction, which is highly dependent on the large-scale cultivation of Curcuma longa L. It requires multiple steps such as rhizome harvesting, cleaning, drying, crushing, solvent extraction, and purification. This method not only has problems such as a long growth cycle of Curcuma longa L. (usually 8-10 months), occupation of a large amount of cultivated land resources, high energy consumption in the preparation process, and high costs, but also is greatly affected by climate and soil conditions, resulting in large consumption of natural resources and unstable output. With the rapid development of synthetic biology technology, heterologous microbial synthesis of curcumin has been successfully realized. Researchers use microorganisms such as Escherichia coli, Yarrowia lipolytica, and Aspergillus oryzae as chassis cells, and reconstruct the biosynthetic pathway of curcumin through gene editing technology, which can achieve efficient, green, and large-scale production of curcumin. This technology not only solves many drawbacks of the traditional plant extraction method, but also effectively improves product purity and reduces production costs, and has become the mainstream technical direction to replace the traditional plant extraction method.

II. Physicochemical Properties of Curcumin

1. Basic Structure

The molecular formula of curcumin is C21H20O6, with a relative molecular mass of 368.38, which belongs to a typical diarylheptane compound. Its chemical structure has distinct characteristics: the main structure contains two symmetric aromatic rings, which are connected by a three-carbon α,β-unsaturated ketone structure, and each aromatic ring is connected with a phenolic hydroxyl group. These structures together form the active core group of curcumin. Among them, the phenolic hydroxyl group is the key structure for curcumin to exert biological activities such as antioxidation and anti-inflammation, while the α,β-unsaturated ketone structure endows it with certain chemical reaction activity, providing possibilities for subsequent structural modification and modification.

2. Solubility

Curcumin has obvious polarity differences in solubility. It is a fat-soluble compound and is almost insoluble in cold water and hot water, which is also a key shortcoming restricting its wide application in food, medicine and other fields. However, curcumin is easily soluble in organic solvents such as ethanol, acetone, ethyl acetate, and glacial acetic acid, and has a certain solubility in halogenated hydrocarbons such as chloroform and dichloromethane. At the same time, it can be dissolved in alkaline solutions to form stable salts, and its solubility will increase slightly with the increase of solution pH value. Due to its extremely poor water solubility, it is difficult to be absorbed and utilized by the human body when applied directly. Therefore, subsequent formulation technology improvement is needed to enhance its water solubility and bioavailability.

3. Stability

The chemical stability of curcumin is greatly affected by environmental conditions. It is relatively stable in an acidic environment (pH<7) and not easy to degrade, which is an important reason for its stable existence in acidic foods and health products. In neutral or alkaline conditions, curcumin is prone to hydrolytic degradation, especially when pH>10, the degradation rate will accelerate significantly, with a degradation rate of more than 50% within 15 hours, and finally decompose into small molecular substances such as vanillin and ferulic acid. In addition, curcumin is relatively sensitive to light and high temperature. Under strong light irradiation or high temperature (above 60℃), it is prone to oxidative decomposition, leading to darkening of its color and reduction of activity. Based on this characteristic, curcumin can be used as a natural pH indicator, which is yellow in acidic or neutral environment and brownish red in alkaline environment, with obvious and reversible color change.

4. Spectral Properties

The pure product of curcumin is an orange-yellow crystalline powder with no obvious odor, and its appearance color will vary slightly with purity and crystallization conditions. As a polyphenolic compound with a conjugated system, curcumin has a characteristic UV-visible absorption spectrum, with the strongest absorption peak at 420-430nm wavelength, which can be quickly qualitatively and quantitatively detected by ultraviolet spectrophotometry. At the same time, curcumin has a clear mass spectrum signal, which can show a characteristic molecular ion peak in mass spectrometry analysis. Combined with technologies such as high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS), it can realize accurate quantitative detection of curcumin in complex samples with a detection accuracy of microgram level, which is widely used in quality control in food, medicine and other fields.

III. Biological Functions and Mechanisms of Curcumin

As a natural active ingredient with multiple targets and pathways, curcumin has extremely high safety. A large number of toxicological studies have confirmed that its acute toxicity and chronic toxicity are relatively low, and there are almost no obvious toxic and side effects under normal doses. Therefore, it has been widely used in many fields such as medicine, food, feed, and cosmetics. As an "evergreen tree" of natural anti-inflammatory and antioxidant substances, curcumin has become one of the commonly used dietary supplements for Americans in daily health care due to its significant physiological activities, which is often used to relieve joint inflammation and improve metabolic health.

(I) Core Functions and Mechanisms

1. Antioxidation

The antioxidant effect of curcumin is mainly achieved through two pathways: on the one hand, the phenolic hydroxyl group in its molecular structure has a strong hydrogen donor capacity, which can directly scavenge reactive oxygen free radicals such as superoxide anion, hydroxyl radical, and hydrogen peroxide produced in the body, reduce the oxidative damage of free radicals to biological macromolecules such as cell DNA, protein, and lipid, thereby delaying cell aging and preventing oxidative stress-related diseases. On the other hand, curcumin can activate the Nrf2/Keap1 signaling pathway in the body, which is the core pathway for the body to regulate antioxidant defense. After activation, it can up-regulate the expression levels of various antioxidant enzymes such as superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and heme oxygenase-1 (HO-1), enhance the body's own antioxidant capacity, reduce the accumulation of reactive oxygen species from the root, and achieve dual antioxidant protection.

2. Anti-inflammation

Curcumin has broad-spectrum and mild anti-inflammatory activity, which can inhibit the occurrence and development of inflammatory responses through multiple targets and pathways. Its core mechanisms of action include: inhibiting the activation of key inflammatory signaling pathways such as NF-κB, MAPK, and TLR4. These pathways are the core regulatory pathways of inflammatory responses. After being inhibited, they can significantly reduce the release of pro-inflammatory factors such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). At the same time, curcumin can also inhibit the activation of NLRP3 inflammasome, reduce the activity of Caspase-1, and reduce the maturation and release of inflammatory factors, thereby effectively relieving tissue damage caused by acute inflammation (such as inflammation caused by tissue damage and infection) and chronic inflammation (such as arthritis, enteritis, chronic hepatitis, etc.), without the gastrointestinal irritation and other side effects of conventional anti-inflammatory drugs.

3. Anti-tumor

The anti-tumor effect of curcumin is characterized by multiple targets and mechanisms, which can inhibit the occurrence, development and metastasis of tumors from multiple links. Specifically, curcumin can inhibit the abnormal activation of various carcinogenic signaling pathways such as PI3K/Akt/mTOR and Wnt/β-catenin, inhibit the proliferation of tumor cells, induce tumor cells to enter G0/G1 phase or G2/M phase cycle arrest, thereby preventing the division and growth of tumor cells. At the same time, curcumin can activate the apoptotic signaling pathway of tumor cells, induce tumor cell apoptosis, and reduce the number of tumor cells. In addition, curcumin can also inhibit the epithelial-mesenchymal transition (EMT) process, reduce the invasiveness of tumor cells, and at the same time inhibit tumor angiogenesis, reduce tumor nutrient supply, improve the tumor immunosuppressive microenvironment, enhance the body's immune surveillance and clearance ability of tumor cells, thereby reducing the risk of tumor metastasis and providing a new idea for the adjuvant treatment of tumors.

4. Metabolic Regulation

Curcumin has a significant effect in metabolic regulation, especially in improving glucose and lipid metabolism. On the one hand, curcumin can improve the sensitivity of body cells to insulin, improve insulin resistance, promote the uptake and utilization of glucose, thereby effectively reducing blood glucose levels, and has a certain auxiliary improvement effect on type 2 diabetes. On the other hand, curcumin can inhibit the expression of fat synthesis-related enzymes such as fatty acid synthase (FASN) and acetyl-CoA carboxylase (ACC), inhibit the synthesis and proliferation of adipocytes, and at the same time promote the oxidative decomposition of fatty acids, reduce the deposition of fat in the liver, abdomen and other parts, thereby improving blood lipid levels and reducing the risk of metabolic diseases such as obesity and fatty liver.

5. Other Functions

In addition to the above core functions, curcumin also has a variety of other physiological activities: in terms of antibacterial and antiviral effects, curcumin has a certain inhibitory effect on common pathogenic bacteria such as Escherichia coli, Staphylococcus aureus, and Helicobacter pylori, and also has a certain inhibitory effect on human immunodeficiency virus (HIV), influenza virus, etc., which can assist in the prevention of infectious diseases. In terms of neuroprotection, curcumin can reduce the aggregation of β-amyloid (Aβ), regulate the phosphorylation level of Tau protein, reduce the damage of nerve cells, improve cognitive function, and has a certain auxiliary protective effect on neurodegenerative diseases such as Alzheimer's disease. In terms of liver and kidney protection, curcumin can repair liver and kidney tissue damage by relieving oxidative stress and inhibiting the fibrosis process related to liver and kidney function damage, and reduce the damage of drugs and poisons to the liver and kidney. It is worth noting that tetrahydrocurcumin is the main active metabolite of curcumin that exerts biological effects in the body. After curcumin enters the human body, it can be catalytically reduced by NADPH-dependent curcumin/dihydrocurcumin reductase in intestinal Escherichia coli to generate tetrahydrocurcumin. Relevant studies have shown that when curcumin is taken orally at a high dose, due to its low bioavailability, the content of curcumin in the blood is extremely low, while the content of tetrahydrocurcumin is significantly increased, and its activity is even better than that of curcumin itself, which is the key substance for curcumin to exert its effects in the body.

(II) Application Scenarios

Pharmaceutical field: It is mainly used for the adjuvant treatment of inflammation, tumors, metabolic syndrome, neurodegenerative diseases, etc., which can relieve patients' symptoms and improve prognosis. At the same time, it can be used as a lead compound for drug research and development to develop new anti-inflammatory and anti-tumor drugs;
Food field: As a natural yellow pigment, it can be used for coloring meat products, condiments, beverages, pastries and other foods, with natural color and no residue. At the same time, as a natural preservative and antioxidant, it can extend the shelf life of food, inhibit food oxidative deterioration, and improve food quality;
Feed field: As a natural substitute for antibiotics, it can be added to livestock and aquatic feed, which can improve the growth performance and immunity of livestock and aquatic animals, reduce the occurrence of diseases, and at the same time improve meat quality and reduce backfat thickness, meeting the needs of green breeding;
Cosmetics field: With its significant antioxidant and anti-inflammatory activities, it can be added to skin care products and cosmetics, which can scavenge skin free radicals, delay skin aging, and at the same time have the effects of brightening skin tone, soothing skin sensitivity, and improving skin inflammation, which is suitable for all skin types.

IV. Biosynthetic Pathway of Curcumin

(I) Natural Pathway in Plants

The core pathway for the natural synthesis of curcumin in plants such as Curcuma longa L. is the phenylpropanoid/polyketide composite pathway, which involves multiple enzymatic reaction steps to form a complete synthetic chain. The core synthetic process is: phenylalanine → cinnamic acid → coumaric acid → caffeic acid → ferulic acid → feruloyl-CoA → curcumin. In this synthetic process, there are multiple key rate-limiting enzymes, whose activity directly determines the synthesis efficiency and yield of curcumin, including:

4-Coumaroyl-CoA ligase (4CL): As one of the key enzymes in the synthetic process, it mainly catalyzes the combination of ferulic acid and Coenzyme A to generate feruloyl-CoA. This reaction is an important prerequisite step for curcumin synthesis, and its activity directly affects the progress of subsequent reactions;
Acetyl-CoA carboxylase (ACC): It mainly catalyzes the carboxylation of acetyl-CoA to generate malonyl-CoA. Malonyl-CoA is an important substrate in the curcumin synthesis process. The activity of ACC can determine the supply of malonyl-CoA, thereby affecting the synthesis yield of curcumin;
Diketide-CoA synthase (DCS): It catalyzes the condensation reaction between feruloyl-CoA and malonyl-CoA to generate β-ketide-CoA. This reaction is a key condensation step in the curcumin synthesis process, laying the foundation for the subsequent formation of curcumin;
Curcumin synthase (CURS): As the key rate-limiting enzyme for curcumin synthesis, it mainly catalyzes the condensation reaction between β-ketide-CoA and another molecule of feruloyl-CoA to finally generate curcumin. The activity of this enzyme is the core factor determining the yield of curcumin in plants.

(II) Main Microbial Synthesis Pathway (Escherichia coli)

To solve the problems of low efficiency and high cost of natural plant synthesis of curcumin, the field of synthetic biology adopts a simplified heterologous synthesis pathway, using Escherichia coli as the chassis cell to achieve efficient synthesis of curcumin. This pathway uses ferulic acid as the main substrate, and realizes one-step synthesis of curcumin by introducing three types of key genes, which greatly simplifies the synthesis steps and improves the synthesis efficiency. The specific key genes and their functions are as follows:

4CL gene: Encodes 4-coumaroyl-CoA ligase, whose main function is to convert the substrate ferulic acid into feruloyl-CoA, providing key intermediate products for curcumin synthesis;
ACC gene: Encodes acetyl-CoA carboxylase. By enhancing the expression of this gene, the supply of malonyl-CoA in Escherichia coli can be significantly increased, solving the problem of insufficient substrate supply, thereby improving the synthesis yield of curcumin;
Non-natural fusion gene DCS::CURS: The diketide-CoA synthase (DCS) gene and curcumin synthase (CURS) gene are fused and expressed to construct a non-natural fusion gene. This fusion enzyme can complete the two-step catalytic reactions of DCS and CURS in one step. Compared with the traditional step-by-step enzyme catalysis, the efficiency is increased by about 1 time, which significantly improves the synthesis yield of curcumin and reduces the production cost.

(III) Representative Engineering Bacteria and Yield

The domestic research team led by Zhang Le constructed Escherichia coli BL21 (DE3) engineering bacteria. By introducing three recombinant plasmids: pRSF-duet-1-ACC, pCDF-duet-1-4CL, and pET-22b-DCS::ZoCURS, the expression of key enzymes was enhanced. Using a two-step fermentation process combined with AB-8 macroporous resin adsorption and purification technology, the final curcumin yield reached 386.8 mg/L. This yield was at a high level in similar domestic studies at that time, providing important technical support for the large-scale microbial production of curcumin;
International research teams have further optimized the gene expression regulation and fermentation process parameters of engineering bacteria. When ferulic acid is used as the substrate, the curcumin yield can be increased to 563.4 mg/L. At the same time, by constructing a co-culture system, de novo synthesis of curcumin (synthetic pathway: tyrosine → ferulic acid → curcumin) is realized without additional addition of ferulic acid substrate. The total yield is 6.6 times higher than that of single engineering bacteria fermentation, which further promotes the industrial application of curcumin microbial synthesis technology.

V. Market Analysis of Curcumin

(I) Market Size and Growth

Global market: With the continuous exploration of curcumin's physiological activities and the continuous expansion of application fields, the global curcumin market size shows a steady growth trend. According to industry research data, the global curcumin market size will be between 215 million and 596 million US dollars in 2025, and the differences in forecasts by different institutions are mainly due to the judgment on the penetration rate of application fields. It is estimated that by 2030, the global market size will grow to 285 million to 783 million US dollars. Among them, the global market research institution GII predicts that the compound annual growth rate (CAGR) of the global curcumin market from 2025 to 2030 will be 11.33%, showing a steady growth momentum. In terms of product dosage forms, powder dosage forms account for about 68% due to the advantages of convenient storage and wide application, which is the mainstream dosage form in the current market. In terms of product types, conventional curcumin accounts for about 55%, and the proportion of high bioavailability curcumin and derivative products is gradually increasing.
Chinese market: As a major producer and consumer of Curcuma longa L. and curcumin in the world, China is also one of the core consumer markets in the world, with a market growth rate much higher than the global average. The size of China's curcumin market was about 468 million yuan in 2025. With the rapid development of the big health industry, consumption upgrading and the continuous expansion of application fields, it is estimated that the market size will exceed 2 billion yuan by 2030, with a compound annual growth rate (CAGR) of more than 33% from 2025 to 2030, becoming the core growth engine of the global curcumin market.
In terms of output: At present, the global production of curcumin is still mainly based on plant extraction, and microbial synthesis technology is in the stage of gradual industrialization. In 2025, the global output of curcumin with 95% purity is about 6,700 tons. With the continuous growth of demand in food, feed, medicine and other fields, the market supply is still tight, which also provides a broad space for the industrialization of curcumin microbial synthesis technology.

(II) Market Driving Factors

Upgrading of healthy consumption: With the improvement of residents' living standards and the enhancement of health awareness, the demand for natural, safe and functional health products has exploded. The core physiological functions of curcumin such as anti-inflammation, antioxidation, liver protection, joint health and metabolic management are exactly in line with the current "Healthy China" strategy and the consumption trend of homology of medicine and food, promoting the rapid growth of its demand in dietary supplements, functional foods and other fields.
Promotion of anti-antibiotic and green breeding policies: Anti-antibiotic policies in feed have been gradually implemented worldwide, and China has also clearly proposed to promote the reduction and replacement of antibiotics in the breeding link. As a natural and safe substitute for antibiotics, curcumin can effectively improve the growth performance and immunity of livestock and aquatic animals, improve meat quality and reduce backfat thickness, which is in line with the development needs of green breeding. The demand in the feed end continues to expand, becoming an important driving force for the growth of the curcumin market.
Breakthrough in formulation technology: The poor water solubility and low bioavailability of curcumin have long restricted its application. In recent years, new formulation technologies such as nanoparticles, liposomes, cyclodextrin inclusion, and phospholipid complexes have continuously made breakthroughs. These technologies can make curcumin into nano-formulations, sustained-release formulations, etc., increasing its bioavailability to 20-30 times that of ordinary formulations, effectively solving its application bottleneck and expanding its application scenarios in medicine, cosmetics and other fields.
Maturity of synthetic biology mass production technology: With the continuous progress of synthetic biology technology, the microbial synthesis technology of curcumin has gradually realized industrialization. Compared with the traditional plant extraction method, microbial synthesis has the advantages of reduced cost, improved purity, no pesticide residues, short production cycle, and no restriction by natural conditions. It can realize large-scale and green production, promote the price reduction of curcumin products, and further expand the scope of its market application.

(III) Application Structure

Dietary supplements: At present, it is the main application field of curcumin, accounting for the highest proportion of the overall market share. Products mainly focus on functions such as anti-inflammation, liver protection, joint health and metabolic regulation, in the forms of capsules, tablets, powders, etc. The audience is mainly middle-aged and elderly people, fitness people and people with chronic inflammation.
Food and beverages: As a natural pigment and functional ingredient, curcumin has the fastest growth rate in the application of food and beverage fields. It is mainly used in meat products, condiments, fruit juices, tea drinks, meal replacement foods and other products. It can not only play a coloring role, but also endow products with functional properties such as antioxidation and anti-inflammation, meeting consumers' demand for natural and healthy foods.
Feed: With the promotion of anti-antibiotic policies, the application of curcumin in the feed field is rapidly expanding. It is mainly added to livestock and aquatic feeds such as pigs, chickens and aquatic products. As a substitute for antibiotics, it can improve animal immunity, reduce the occurrence of diseases, and at the same time improve meat quality, promoting the development of green breeding.
Cosmetics: With its antioxidant, anti-inflammatory and skin-brightening effects, curcumin is increasingly used in the cosmetics field. It is mainly used in skin care products, masks, essences and other products, which can relieve skin sensitivity, improve dull skin tone, delay skin aging, and is widely recognized by consumers.
Medicine: At present, curcumin is mainly used for the adjuvant treatment of diseases such as inflammation, tumors and metabolic syndrome in the medical field. Related drugs are in the rapid transformation stage. With the deepening of clinical research, its application potential in the medical field will be further released.

(IV) Approval Status in Major Global Markets

1. Approval Status in the United States

GRAS certification: Purified curcumin and curcumin complexes (such as Curcumin C3 Complex®) have obtained GRAS (Generally Recognized as Safe) certification from the U.S. Food and Drug Administration (FDA) (certification number GRN 460, etc.). After certification, curcumin can be used as a food ingredient and flavor enhancer in various foods such as baked goods, snacks, meal replacement products, and dietary supplements without additional safety evaluation.
Dietary supplements: Curcumin can be legally marketed as a raw material for dietary supplements. Products mainly focus on functions such as anti-inflammation, antioxidation and joint health. They do not need to go through the new drug approval process, but must strictly abide by the relevant U.S. regulations on dietary supplements. They are not allowed to claim to have disease treatment effects, but only can mark their physiological functions.
Drugs: At present, new molecular entities related to curcumin are still in the clinical trial stage, mainly used for the treatment of diseases such as inflammation and tumors. There are no curcumin-based new drugs approved by the FDA yet, and relevant clinical research is still ongoing.

2. Approval Status in the European Union

Food additives: The European Union classifies curcumin as a food colorant with the number E100 (Curcumin), approving it for use in various foods and solid dietary supplements, and clarifying its usage limit standards to ensure product safety. The European Food Safety Authority (EFSA) has completed the re-evaluation of the safety of curcumin, setting the Acceptable Daily Intake (ADI) at 0–3 mg/kg bw/day (0–3 milligrams per kilogram of body weight per day), providing a safety basis for its application in the EU market.
Feed additives: The European Union has approved curcumin as a natural feed additive, which can be used in livestock and aquatic feeds, mainly playing the role of natural coloring and health care. It can improve animal growth performance and enhance immunity, in line with the relevant requirements of EU green breeding, and its application scope is gradually expanding.

3. Certification by International Organizations

JECFA (Joint FAO/WHO Expert Committee on Food Additives): Officially approved curcumin as a food additive in 1995, and formulated a globally applicable safety standard, setting its Acceptable Daily Intake (ADI) at 0–3 mg/kg body weight/day. This standard has been adopted by most countries and regions in the world, providing a unified safety basis for the global application of curcumin.
WHO (World Health Organization): Clearly recognizes curcumin as a safe natural pigment and functional ingredient, recommends its wide application in food, health products, medicine and other fields, and encourages relevant research institutions to further explore its physiological activities and promote its industrial application.

(V) Competitive Pattern

International enterprises: At present, the leading enterprises in the global curcumin market are mainly international giants, including Indena from Italy, Sabinsa from the United States, Synthite and Arpan from India. With advanced extraction technology, formulation technology, brand advantages and a complete global sales network, these enterprises occupy the main share of the global mid-to-high-end curcumin market, and their products are mainly high-purity, high-bioavailability curcumin and derivatives.
Chinese enterprises: In recent years, Chinese curcumin enterprises have developed rapidly, mainly including Zhongda Biology, Chenguang Biology, Tianxu Biology, etc. Relying on China's advantages in Curcuma longa L. planting resources and the rapid development of synthetic biology technology, these enterprises have obvious advantages in cost control. Their products are mainly conventional curcumin and plant extracts, and they are gradually expanding to high-bioavailability formulations and microbial synthetic curcumin fields, with their market share gradually increasing.
Core barriers: At present, the core competitive barriers in the curcumin market are mainly concentrated in three aspects: first, high bioavailability formulation technology, which can effectively solve the problems of poor water solubility and low bioavailability of curcumin, and is the key to improving product competitiveness; second, the optimization of microbial synthesis pathways, which can realize low-cost and large-scale production of curcumin, breaking the limitations of traditional plant extraction; third, clinical evidence and compliance. Especially in the medical and dietary supplement fields, the clinical data support and compliance of products are important prerequisites for entering the market.

(VI) Trends and Prospects

Production end: Synthetic biology technology will gradually replace the traditional plant extraction method and become the mainstream production method of curcumin. In the future, the focus will be on promoting the high-yield and low-cost transformation of engineering bacteria such as Escherichia coli and yeast, realizing the green, sustainable and large-scale production of curcumin, and at the same time reducing product prices and expanding the application scope.
Product end: High bioavailability dosage forms, curcumin derivatives (such as tetrahydrocurcumin, curcumin phospholipid complexes, etc.) and precise targeted delivery formulations will become the market mainstream. These products can effectively improve the bioavailability and physiological activity of curcumin, meet the needs of different fields and groups of people, and the product added value will be significantly improved.
Application end: The application field of curcumin will be further extended. From the current fields such as dietary supplements, food and beverages, and feed, it will gradually expand to medicine (clinical treatment), high-end feed, functional cosmetics and other fields, with increasingly rich application scenarios and continuous growth in market demand.
Market end: China will continue to be the core growth area of the global curcumin market. At present, the penetration rate of China's curcumin market is still low. With the upgrading of healthy consumption, the promotion of anti-antibiotic policies and technological breakthroughs, the market space is broad, and it will maintain a high prosperity for a long time. At the same time, Chinese enterprises will gradually enhance their brand influence and participate in global market competition.

(VII) Summary

Clear functions, wide applications, large market scale and rapid growth. The core physiological activities of curcumin such as anti-inflammation and antioxidation have been fully verified, covering multiple high-demand fields such as medicine, food, feed and cosmetics, with great market development potential;
The biosynthetic pathway is clear, the mechanism of action of key enzymes is clear and the technology is mature, and the technology for constructing and optimizing engineering bacteria is constantly breaking through, which can realize efficient and large-scale production with high technical feasibility;
The industry pain points are clear. The existence of poor water solubility and low bioavailability of curcumin provides a broad space for its structural modification and formulation upgrading, and can improve product competitiveness and create higher added value through technological innovation;
It is in line with the global development trends of green manufacturing, the big health industry and anti-antibiotic policies. It not only has important scientific research value, which can promote the industrial application of synthetic biology technology, but also can bring significant commercial returns, with broad market prospects.

Go back →